Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0001213900-25-113113

Director disposed of 3,090,892 shares (other)

  • Director acquired 11,818 shares (other)

From the SEC's structured data for this filing

Trades in this filing

M33 Growth I L.P. · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Owned after D/I
2025-11-18 Other disposition : show line 1 in the form −590,892 0 I
2025-11-18 Other acquisition : show line 2 in the form +11,818 7,944,207 D
2025-11-18 Other disposition : show line 3 in the form −2,500,000 5,444,207 D
Loading xslF345X05/ownership.xml…